Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 13A is a protein coded by the TEX13A gene, predominantly expressed in the testis. It plays a role in transcriptional repression and is required for rapid sperm motility and timely degradation of mRNA via its interaction with the CNOT1 component of the CCR4-NOT complex. Alternative splicing leads to multiple transcript variants. There are disease associations, including certain forms of X-linked deafness and syndromes with intellectual disability, but currently the protein is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 13A (TEX13A).